Lexicon Pharmaceuticals Stock (NASDAQ: LXRX) stock price, news, charts, stock research, profile.
Open | $1.59 |
Close | - |
Volume / Avg. | 1.43M / 2.86M |
Day Range | $1.53 - $1.60 |
52 Wk Range | 0.92 - 3.73 |
Market Cap | $565.74M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 15.58% |
Days to Cover | 8.64 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lexicon Pharmaceuticals (NASDAQ:LXRX) through any online brokerage.
Other companies in Lexicon Pharmaceuticals’s space includes: Humacyte (NASDAQ:HUMA), 4D Molecular Therapeutics (NASDAQ:FDMT), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC) and Altimmune (NASDAQ:ALT).
Lexicon Pharmaceuticals has a consensus price target of $7.20.
The stock price for Lexicon Pharmaceuticals (NASDAQ: LXRX) is $1.565 last updated September 24, 2024 at 1:51 PM EDT.
There are no upcoming dividends for Lexicon Pharmaceuticals.
Lexicon Pharmaceuticals’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Lexicon Pharmaceuticals.
Lexicon Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.